Next Article in Journal
Exploring Environmentally Friendly Biopolymer Material Effect on Soil Tensile and Compressive Behavior
Next Article in Special Issue
Heart Rate Variability in Women with Systemic Lupus Erythematosus: Association with Health-Related Parameters and Effects of Aerobic Exercise
Previous Article in Journal
Intervention Effects of the Health Promotion Programme “Join the Healthy Boat” on Objectively Assessed Sedentary Time in Primary School Children in Germany
Previous Article in Special Issue
Is Weight Gain Inevitable for Patients Trying to Quit Smoking as Part of Cardiac Rehabilitation?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 17
Issue 23
10.3390/ijerph17239031
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Associations between Health-Related Physical Fitness and Cardiovascular Disease Risk Factors in Overweight and Obese University Staff

by
Jiangang Chen
1,
Yuan Zhou
1,
Xinliang Pan
2,
Xiaolong Li
1,
Jiamin Long
1,
Hui Zhang
1 and
Jing Zhang
1,*
1
Department of Exercise Science, School of Physical Education, Shaanxi Normal University, Xi‘an 710119, China
2
School of Kinesiology, Beijing Sport University, Beijing 100084, China
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2020, 17(23), 9031; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph17239031
Submission received: 28 October 2020 / Revised: 1 December 2020 / Accepted: 1 December 2020 / Published: 3 December 2020
(This article belongs to the Special Issue Physical Activity, Physical Fitness, and Exercise Interventions for Preserving Human Health and Preventing and Treating Chronic Conditions across the Lifespan)
Browse Figure
Review Reports Versions Notes

Abstract

:
Purpose: This cross-sectional study examined the associations between health-related physical fitness (HPF) and cardiovascular disease (CVD) risk factors in overweight and obese university staff. Methods: A total of 340 university staff (109 women, mean age 43.1 ± 9.7 years) with overweight (n = 284) and obesity (n = 56) were included. The HPF indicators included skeletal muscle mass index (SMI), body fat percentage (BFP), grip strength (GS), sit-and-reach test (SRT), and vital capacity index (VCI). CVD risk factors were measured, including uric acid (UA), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and glucose (GLU). Results: BFP, SMI, and GS were positively associated with UA level (β = 0.239, β = 0.159, β = 0.139, p < 0.05). BFP was positively associated with TG and TG/HDL-C levels (β = 0.421, β = 0.259, p < 0.05). GS was positively associated with HDL-C level (β = 0.244, p < 0.05). SRT was negatively associated with GLU level (β = −0.130, p < 0.05). Conclusions: In overweight and obese university staff, body composition, muscle strength, and flexibility were associated with CVD risk factors. An HPF test may be a practical nonmedical method to assess CVD risk.

Graphical Abstract

1. Introduction

Cardiovascular disease (CVD) is a significant public health issue, as it is the leading cause of adult mortality, accounting for more than 40% of deaths in China [1]. Over the past 30 years, the number of CVD deaths in China has increased from 2.51 million to 3.97 million annually [2]. Although the age-standardized mortality rate remained stable overall from 2002 to 2016, it increased among the young population [3]. Therefore, the early prevention of CVD is essential [4].
The risk factors of CVD include dyslipidemia, diabetes, and obesity [5]. In recent years, hyperuricemia has also been recognized as a potential risk factor for CVD, following the discovery of a causal relationship between uric acid and the adverse outcomes of CVD [6,7]. Among the many risk factors, obesity affects cardiovascular disease in several ways; for instance, obesity affects the morbidity of CVD, and early obesity may increase the risk of future CVD events [8]. Obesity also affects the prognosis of CVD. A meta-analysis showed that overweight and obese individuals had 25% and 42% increased risks of CVD mortality, respectively, compared to those of normal-weight individuals [9]. Furthermore, the duration of obesity may also affect CVD. Abdullah et al. [10] found that every two years of obese living significantly increased the risk of CVD mortality by 7%. This may be because obesity worsens other CVD risk factors such as blood lipid and blood glucose levels [11]. It is necessary, therefore, to assess the risk factors of CVD in overweight and obese individuals.
Common measures of obesity include body mass index (BMI) and body composition. Body composition is one of the components of health-related physical fitness (HPF). In addition to body composition, other HPF components include cardiorespiratory fitness, muscular fitness, and flexibility. HPF reflects not only the ability of the body to participate in exercise, but also the body’s ability to reduce the risk of disease. HPF assessment, therefore, may have important implications in the prevention of chronic diseases. Previous studies have shown that HPF can predict multiple risk factors for CVD [12,13,14]. Body composition is better at distinguishing between fat mass and fat-free mass than BMI. Studies have shown that individuals with the same BMI may differ in body composition, which affects their risks of CVD [15]. Cardiorespiratory fitness (CRF) is one of the most important HPF factors, and it is a strong predictor of CVD [16,17]. The respiratory function, however, also plays an important role in cardiovascular health [18], and it is not clear whether indicators of respiratory function can be used to assess the risk of CVD. In recent years, the relationship between muscular fitness and CVD has gradually attracted attention. Grip strength has a negative correlation with triglyceride and glucose levels [19], and decreased respiratory muscle strength is an independent risk factor for CVD [20]. The relationship between muscle strength and uric acid level may vary between populations. One study reported a negative correlation between grip strength and uric acid in young people but a positive correlation in older people [21]. Flexibility may also be an indicator of CVD risk. Chang et al. found that flexibility was positively correlated with high-density lipoprotein levels among 628 community residents but did not control other variables such as sex and age [22]. Thus, the relationship between flexibility and CVD requires further exploration.
To the best of our knowledge, numerous studies have been conducted on the relationship between HPF and CVD in normal-weight individuals [13,22]. No study, however, has focused on overweight and obese university staff. A cross-sectional study found that 94 percent of university staff were exposed to one or more CVD risk factors [23]. This may indicate that university staff have a higher risk of cardiovascular disease. Furthermore, university staff have a higher prevalence of overweight and obesity than the general population does because of longer working hours and psychosocial factors [24]. Cardiovascular disease risk factors, such as blood lipids, glucose, and uric acid levels, may further worsen among university staff in overweight and obese states. The purpose of this study, therefore, was to explore the associations between HPF and CVD risk factors in overweight and obese university staff and to provide a basis for HPF testing in evaluating the risk of CVD and the development of future exercise intervention strategies.

2. Materials and Methods

2.1. Participants and Study Design

From October 2019 to January 2020, a total of 2800 university staff underwent annual health screenings at the Community Hospital Health Management Center. This cross-sectional study recruited university staff every morning in the breakfast serving area of the Health Management Center. A sample size of 319 was required to achieve 90% statistical power based on the calculation of PASS.11.0, and 412 university staff were actually recruited. Among the 412 participants, 38 participants did not complete HPF tests, and 34 participants were over 60 years. A total of 340 overweight and obese university staff aged between 25 and 60, with a BMI greater than 24.0, were eventually included in the study. The classification criteria for overweight and obesity were from the China Obesity Working Group [25].
Participants first underwent a blood collection procedure, and then height, weight, and body composition were measured. Other HPF tests were performed after participants ate breakfast and took a 15 min break to regain their strength. The participants were informed of the test procedures, requirements, and possible risks before the test, and they signed the informed consent forms. The protocols were approved by the Ethics Committee of Shaanxi Normal University, and the ethical approval code is 202016003.

2.2. Study Variables

2.2.1. Health-Related Physical Fitness Measurement

Health-related physical fitness indicators were measured by trained research assistants according to the National Physical Fitness Standards Manual.
Body height and weight were measured using an all-in-one machine (GK 720, Shandong, China), which combined an ultrasonic stadiometer with an electronic weight scale. The machine was calibrated before each use to ensure accuracy. Participants stood barefoot in a designated position and looked straight ahead. The test results were automatically recorded and reported.
Body composition was assessed with a bioelectrical impedance machine (InBody 230, Seoul, South Korea). Participants stood barefoot on the electrodes of the machine and held the handles with both hands. Participants remained in a natural standing position throughout the test and always kept their hands and feet in contact with the electrodes. The test program took 1 to 2 min, and skeletal muscle mass (SMM) and total body fat mass (BFM) were automatically recorded by the InBody 230. Skeletal muscle mass index (SMI) was determined using SMM divided by height squared. Body fat percentage (BFP) was determined using BFM divided by body weight.
Grip strength was measured using a portable electronic grip strength dynamometer (Hengkangjiaye, Guangzhou, China). Participants stood naturally with their arms slanting down and their palms inward. Participants were not allowed to swing their arms or hold the dynamometer close to their bodies during the test. Each hand was tested twice, and the highest measurements were recorded.
Flexibility was assessed with the sit-and-reach test (SRT). An electronic fleximeter (HKD-1442, Beijing, China) was used to achieve better accuracy. Participants sat barefoot in the required position with their legs straight and their feet together. During each measurement, participants pushed their feet against the front baffle and stretched their arms as far forward as possible. Measurements were recorded to evaluate flexibility as participants tried to push the cursor on the farthest scale with the fingertips of their hands. Participants tried three times, and the largest measurements were recorded.
Vital capacity (VC) was measured using an electronic pneumometer (WCS-1000, Beijing, China). Participants inhaled deeply and then exhaled all the air to assess vital capacity. Participants tried this three times, and the maximum exhalation was recorded. Participants were asked to rest 30–60 s between the three measurements in order to avoid hypoxia. Vital capacity Index (VCI) was determined using VC divided by body weight.

2.2.2. Cardiovascular Disease Factors Measurement

After a night of fasting, blood samples were collected from 8 a.m. to 10 a.m. in the Community Hospital Health Management Center. On the same day, blood specimens were processed and analyzed in the laboratory of the Community Hospital. The automatic analyzer AU480 (Beckman Coulter, California, USA) was used to analyze blood biochemistry. Serum uric acid (UA), triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were measured with enzymatic methods. Blood glucose (GLU) was measured using a hexokinase enzymatic method. TG/HDL-C was, thereafter, used to estimate insulin resistance [26].

2.3. Statistical Analysis

All variables were checked for normality using the Kolmogorov–Smirnov test. Continuous variables with normal distribution were presented by mean ± standard deviation (SD), continuous variables with non-normal distribution were presented by median (interquartile range (IQR)), and categorical variables were presented by number (percentage). Multiple linear regression was used to analyze the associations between HPF and CVD risk factors. Each variable was z-standardized before the regression analysis to compare these values on the same scale. A two-sided p-value < 0.05 was considered statistically significant. SPSS 23.0 software (Chicago, IL, USA) was used for statistical analyses.

3. Results

Table 1 illustrates the baseline characteristics of participants. A total of 340 university staff (109 women, 231 men) were included in this study. Participants’ mean age was 43.1 ± 9.7 years, and 9.1% of participants were 25–30 years, 35.6% were 31–40 years, 26.8% were 41–50 years, and 28.5% were 51–60 years old. Participants’ mean BMI was 26.2 ± 1.9 kg/m2, 83.5% of participants were overweight, and 16.5% were obese.
Table 2 shows the associations between HPF indicators and CVD risk factors. BFP, SMI, and GS were positively associated with UA level (β = 0.239, β = 0.159, β = 0.139, p < 0.05). BFP was positively associated with TG and TG/HDL-C levels (β = 0.421, β = 0.259, p < 0.05). GS was positively associated with HDL-C level (β =0.244, p < 0.05). SRT was negatively associated with GLU level (β = −0.130, p < 0.05).

4. Discussion

This study evaluated the associations between HPF indicators and CVD risk factors in overweight and obese university staff. The main findings of this study were that reduced flexibility was associated with elevated GLU level, while high body fat percentage, muscle mass, and grip strength were associated with high UA level. We also observed that grip strength was positively associated with high-density lipoprotein cholesterol (HDL-C) level and that body fat percentage was positively associated with TG and TG/HDL-C levels. These results indicated that the HPF and CVD risk factors were related, and they provide a basis for nonmedical evaluations of CVD risk in overweight or obese university staff and the development of future exercise intervention strategies.
Our analysis of the association between HPF indicators and UA showed that body fat percentage was positively associated with UA level. This may be attributed to the fact that purine metabolism in adipose tissue is enhanced in obesity [27,28]. Furthermore, the distribution of body fat is closely related to UA level [29]. Huang et al. reported that visceral fat accumulation increased the risk of hyperuricemia in older Chinese adults [30]. This finding suggests that, in addition to the total body fat percentage, visceral fat is also an important indicator to consider in the prevention of hyperuricemia. We also observed that skeletal muscle index and grip strength were positively associated with UA level. This finding is consistent with those of previous cross-sectional studies in the elderly [31,32,33]. UA is the final product of purine metabolism. An excessive accumulation of UA in the body may cause not only gout but also heart failure [6,7]. In recent years, UA has been observed to slow age-related muscle decline [33,34]. In a longitudinal study, Macchi et al. [35] found that in people with an average age of 76 years, higher baseline serum UA levels were associated with better muscle function three years later. This muscular protection, however, was not observed in those under 60 years of age [36]. Furthermore, the possible physiological mechanisms by which UA protects muscles are not clear. Although studies have assumed that UA plays a protective role in the process of free radical damage to skeletal muscle protein [37], UA is also a pro-oxidant and may increase oxidative stress. Another study suggests that UA may be an indicator of dietary protein intake. High UA concentrations in patients with hyperuricemia are associated with better nutritional status [38]. Total protein intake, particularly those of meat and fish proteins, may be important for building and maintaining muscle mass [39]. Individuals with higher dietary protein intake, therefore, may maintain higher muscle mass as well as higher UA levels. Previous studies have shown that high body fat and muscle mass both place a burden on the cardiovascular system and increase the risk of cardiovascular disease [11], indicating that weight control and improvement to body composition are important for overweight and obese university staff.
Our study results revealed that flexibility was negatively associated with GLU level. Aparicio et al. [40] also reported a negative correlation between flexibility and GLU in menopausal women; however, their finding was not statistically significant, probably because flexibility was a self-reported scale score rather than an actual measured value. One possible explanation for the association between flexibility and GLU is disc degeneration. Hyperglycemia has a detrimental effect on disc cell viability, leading to disc degeneration and impaired lumbar flexibility [41]. Inflammatory cytokines, which mediate insulin resistance, also play a role in disc degeneration [42,43]. The relationship between flexibility and GLU metabolism, however, remains poorly understood, and as many factors affecting flexibility and blood glucose are not considered, the exact mechanism is not clear. Studies in recent years have begun to recognize the value of flexibility in evaluating and preventing chronic diseases. Gregorio et al. [44] reported that flexibility not only in the waist but also in the upper body is associated with cardiometabolic risk factors. Another study found that flexibility exercises reduced pro-inflammatory adipokines, such as PAI-1 and chemerin, and increased anti-inflammatory adipokines, such as adiponectin [45]. Future studies are needed to further confirm the effectiveness of flexibility training in reducing blood glucose and preventing CVD.
Our analysis of the relationship between HPF and blood lipids revealed that body fat percentage was positively associated with TG and TG/HDL-C levels. This finding is supported by previous studies using dual-energy X-rays and confirmed that body fat and its distribution are closely related to blood lipid levels [46,47]. Konieczna et al. [46] further compared regional and total body fat measurements, reporting that the ratio of visceral adipose tissue to total fat was a more effective evaluation indicator of TG. This may be because visceral fat mediates partial insulin resistance through the release of inflammatory adipokines [46]. As a result, lipolysis is intensified, and excess TGs enter the liver, causing an abnormally high TG level [48].
We observed that grip strength was positively associated with HDL-C level. Grip strength is an effective indicator of muscle strength and of potential health risks [49]. In a study of 8576 participants, Lee et al. found that participants with low grip strength had increased risks of CVD [50]. Another large sample study determined that higher relative grip strength was associated with healthier blood lipid levels in adults, such as lower TG and total cholesterol levels and higher HDL-C levels [19]. This may be related to the endocrine function of skeletal muscle and its metabolic benefits [51]. Cytokines secreted by the muscles may regulate the metabolic process through autocrine and paracrine mechanisms. Cytokines, such as myonectin and irisin, regulate lipid metabolism and improve insulin resistance [52,53].
One advantage of this study was that we first explored the associations between HPF and CVD risk factors in overweight or obese adults and provided new insight regarding CVD prevention and control strategies. Secondly, the HPF indicators included in this study were easy to measure and obtain. It is convenient, therefore, for the general population to conduct HPF self-assessments. Certainly, this study also has some limitations. Firstly, physical activity, nutritional status, and physiological indicators related to inflammation, such as blood pressure and CRP, were not included in the study. Secondly, our study cannot determine the causal relationship between HPF and CVD risk factors due to the cross-sectional design. Thirdly, the results of this study cannot be generalized for the overall population, as participants were overweight and obese adults. In the future, longitudinal or experimental studies should be considered to verify the causal relationship between HPF and CVD risk factors.

5. Conclusions

Among overweight and obese university staff, reduced flexibility was associated with high glucose level, while high body fat percentage, muscle mass, and grip strength were associated with high uric acid level. Additionally, grip strength was positively associated with HDL-C level, and body fat percentage was positively associated with TG and TG/HDL-C levels. The results of this study suggest that body composition, grip strength, and flexibility may be practical nonmedical markers for assessing cardiovascular disease risk. In the future, prospective studies should be conducted to investigate the extent to which exercise programs that improve body composition and increase muscle strength and flexibility may reduce the risk of cardiovascular disease.

Author Contributions

Conceptualization, J.Z.; methodology, J.C.; software, Y.Z.; formal analysis, J.C.; investigation, X.P., J.L., Y.Z., and H.Z.; data curation, X.L.; writing—original draft preparation, J.C.; writing—review and editing, J.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Project of Consultation of General Administration of Sport of China (YB20180419025), Special Fund for Innovation Guidance of Shaanxi Province (2020QFY01-03), and Special Fund for Basic Scientific Research Expenses of Central Colleges and Universities (18SZYB29).

Acknowledgments

The authors acknowledge the valuable contributions of all investigators and participants.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zhou, M.; Wang, H.; Zhu, J.; Chen, W.; Wang, L.; Liu, S.; Li, Y.; Wang, L.; Liu, Y.; Yin, P.; et al. Cause-specific mortality for 240 causes in China during 1990-2013: A systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 2016, 387, 251–272. [Google Scholar] [CrossRef]
  2. Liu, S.; Li, Y.; Zeng, X.; Wang, H.; Yin, P.; Wang, L.; Liu, Y.; Liu, J.; Qi, J.; Ran, S.; et al. Burden of Cardiovascular Diseases in China, 1990-2016: Findings From the 2016 Global Burden of Disease Study. JAMA Cardiol. 2019, 4, 342–352. [Google Scholar] [CrossRef]
  3. Yu, Q.; Wang, B.; Wang, Y.; Dai, C.L. Level and trend of cardiovascular disease mortality in China from 2002 to 2016. Zhonghua Xin Xue Guan Bing Za Zhi 2019, 47, 479–485. [Google Scholar] [PubMed]
  4. Shen, C.; Ge, J. Epidemic of Cardiovascular Disease in China: Current Perspective and Prospects for the Future. Circulation 2018, 138, 342–344. [Google Scholar] [CrossRef] [PubMed]
  5. Joseph, P.; Leong, D.; McKee, M.; Anand, S.S.; Schwalm, J.D.; Teo, K.; Mente, A.; Yusuf, S. Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors. Circ. Res. 2017, 121, 677–694. [Google Scholar] [CrossRef] [PubMed]
  6. Kleber, M.E.; Delgado, G.; Grammer, T.B.; Silbernagel, G.; Huang, J.; Kramer, B.K.; Ritz, E.; Marz, W. Uric Acid and Cardiovascular Events: A Mendelian Randomization Study. J. Am. Soc. Nephrol. 2015, 26, 2831–2838. [Google Scholar] [CrossRef] [PubMed]
  7. Chiang, K.M.; Tsay, Y.C.; Vincent, N.T.; Yang, H.C.; Huang, Y.T.; Chen, C.H.; Pan, W.H. Is Hyperuricemia, an Early-Onset Metabolic Disorder, Causally Associated with Cardiovascular Disease Events in Han Chinese? J. Clin. Med. 2019, 8, 1202. [Google Scholar] [CrossRef] [Green Version]
  8. Khan, S.S.; Ning, H.; Wilkins, J.T.; Allen, N.; Carnethon, M.; Berry, J.D.; Sweis, R.N.; Lloyd-Jones, D.M. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiol. 2018, 3, 280–287. [Google Scholar] [CrossRef]
  9. Barry, V.W.; Caputo, J.L.; Kang, M. The Joint Association of Fitness and Fatness on Cardiovascular Disease Mortality: A Meta-Analysis. Prog. Cardiovasc. Dis. 2018, 61, 136–141. [Google Scholar] [CrossRef]
  10. Abdullah, A.; Wolfe, R.; Stoelwinder, J.U.; de Courten, M.; Stevenson, C.; Walls, H.L.; Peeters, A. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int. J. Epidemiol. 2011, 40, 985–996. [Google Scholar] [CrossRef] [Green Version]
  11. Ortega, F.B.; Lavie, C.J.; Blair, S.N. Obesity and Cardiovascular Disease. Circ. Res. 2016, 118, 1752–1770. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Penha, J.; Gazolla, F.M.; Carvalho, C.; Madeira, I.R.; Rodrigues-Junior, F.; Machado, E.A.; Sicuro, F.L.; Farinatti, P.; Bouskela, E.; Collett-Solberg, P.F. Physical fitness and activity, metabolic profile, adipokines and endothelial function in children. J. Pediatr. 2019, 95, 531–537. [Google Scholar] [CrossRef] [PubMed]
  13. Medrano, M.; Arenaza, L.; Migueles, J.H.; Rodriguez-Vigil, B.; Ruiz, J.R.; Labayen, I. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity. Pediatr. Diabetes. 2020, 21, 565–574. [Google Scholar] [CrossRef] [PubMed]
  14. Lima, T.R.; Martins, P.C.; Guerra, P.H.; Silva, D. Muscular strength and cardiovascular risk factors in adults: Systematic review. Phys. Sportsmed. 2020, 1, 1–13. [Google Scholar] [CrossRef]
  15. Chen, G.C.; Arthur, R.; Iyengar, N.M.; Kamensky, V.; Xue, X.; Wassertheil-Smoller, S.; Allison, M.A.; Shadyab, A.H.; Wild, R.A.; Sun, Y.; et al. Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. Eur. Heart J. 2019, 40, 2849–2855. [Google Scholar] [CrossRef]
  16. Barry, V.W.; Baruth, M.; Beets, M.W.; Durstine, J.L.; Liu, J.; Blair, S.N. Fitness vs. fatness on all-cause mortality: A meta-analysis. Prog. Cardiovasc. Dis. 2014, 56, 382–390. [Google Scholar] [CrossRef]
  17. Castro-Pinero, J.; Perez-Bey, A.; Segura-Jimenez, V.; Aparicio, V.A.; Gomez-Martinez, S.; Izquierdo-Gomez, R.; Marcos, A.; Ruiz, J.R. Cardiorespiratory Fitness Cutoff Points for Early Detection of Present and Future Cardiovascular Risk in Children: A 2-Year Follow-up Study. Mayo Clin. Proc. 2017, 92, 1753–1762. [Google Scholar] [CrossRef]
  18. Simons, S.O.; Elliott, A.; Sastry, M.; Hendriks, J.M.; Arzt, M.; Rienstra, M.; Kalman, J.M.; Heidbuchel, H.; Nattel, S.; Wesseling, G.; et al. Chronic obstructive pulmonary disease and atrial fibrillation: An interdisciplinary perspective. Eur. Heart J. 2020. [Google Scholar] [CrossRef]
  19. Lawman, H.G.; Troiano, R.P.; Perna, F.M.; Wang, C.Y.; Fryar, C.D.; Ogden, C.L. Associations of Relative Handgrip Strength and Cardiovascular Disease Biomarkers in U.S. Adults, 2011-2012. Am. J. Prev. Med. 2016, 50, 677–683. [Google Scholar] [CrossRef]
  20. Van der Palen, J.; Rea, T.D.; Manolio, T.A.; Lumley, T.; Newman, A.B.; Tracy, R.P.; Enright, P.L.; Psaty, B.M. Respiratory muscle strength and the risk of incident cardiovascular events. Thorax 2004, 59, 1063–1067. [Google Scholar] [CrossRef] [Green Version]
  21. Garcia-Esquinas, E.; Rodriguez-Artalejo, F. Association between serum uric acid concentrations and grip strength: Is there effect modification by age? Clin. Nutr. 2018, 37, 566–572. [Google Scholar] [CrossRef] [PubMed]
  22. Chang, K.V.; Hung, C.Y.; Li, C.M.; Lin, Y.H.; Wang, T.G.; Tsai, K.S.; Han, D.S. Reduced flexibility associated with metabolic syndrome in community-dwelling elders. PLoS ONE 2015, 10, e117167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Sita, C.; Sachita, S.; Mausumi, B.; Raghunath, M. A study on cardiovascular disease risk factors among faculty members of a tertiary care teaching institute of Kolkata. J. Community Health Manag. 2018, 5, 67–71. [Google Scholar] [CrossRef]
  24. Cheong, S.M.; Kandiah, M.; Chinna, K.; Chan, Y.M.; Saad, H.A. Prevalence of obesity and factors associated with it in a worksite setting in Malaysia. J. Community Health 2010, 35, 698–705. [Google Scholar] [CrossRef] [PubMed]
  25. Zhou, B.F. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed. Environ. Sci. 2002, 15, 83–96. [Google Scholar]
  26. Yeh, W.C.; Tsao, Y.C.; Li, W.C.; Tzeng, I.S.; Chen, L.S.; Chen, J.Y. Elevated triglyceride-to-HDL cholesterol ratio is an indicator for insulin resistance in middle-aged and elderly Taiwanese population: A cross-sectional study. Lipids Health Dis. 2019, 18, 176. [Google Scholar] [CrossRef] [Green Version]
  27. Tsushima, Y.; Nishizawa, H.; Tochino, Y.; Nakatsuji, H.; Sekimoto, R.; Nagao, H.; Shirakura, T.; Kato, K.; Imaizumi, K.; Takahashi, H.; et al. Uric acid secretion from adipose tissue and its increase in obesity. J. Biol. Chem. 2013, 288, 27138–27149. [Google Scholar] [CrossRef] [Green Version]
  28. Nagao, H.; Nishizawa, H.; Tanaka, Y.; Fukata, T.; Mizushima, T.; Furuno, M.; Bamba, T.; Tsushima, Y.; Fujishima, Y.; Kita, S.; et al. Hypoxanthine Secretion from Human Adipose Tissue and its Increase in Hypoxia. Obesity 2018, 26, 1168–1178. [Google Scholar] [CrossRef] [Green Version]
  29. Yamada, A.; Sato, K.K.; Kinuhata, S.; Uehara, S.; Endo, G.; Hikita, Y.; Fujimoto, W.Y.; Boyko, E.J.; Hayashi, T. Association of Visceral Fat and Liver Fat With Hyperuricemia. Arthritis Care Res. 2016, 68, 553–561. [Google Scholar] [CrossRef]
  30. Huang, X.; Jiang, X.; Wang, L.; Chen, L.; Wu, Y.; Gao, P.; Hua, F. Visceral adipose accumulation increased the risk of hyperuricemia among middle-aged and elderly adults: A population-based study. J. Transl. Med. 2019, 17, 341. [Google Scholar] [CrossRef] [Green Version]
  31. Kawamoto, R.; Ninomiya, D.; Kasai, Y.; Kusunoki, T.; Ohtsuka, N.; Kumagi, T.; Abe, M. Serum Uric Acid Is Positively Associated with Handgrip Strength among Japanese Community-Dwelling Elderly Women. PLoS ONE 2016, 11, e151044. [Google Scholar] [CrossRef] [PubMed]
  32. Xu, Z.R.; Zhang, Q.; Chen, L.F.; Xu, K.Y.; Xia, J.Y.; Li, S.M.; Yang, Y.M. Characteristics of hyperuricemia in older adults in China and possible associations with sarcopenia. Aging Med. 2018, 1, 23–34. [Google Scholar] [CrossRef] [PubMed]
  33. Wu, Y.; Zhang, D.; Pang, Z.; Jiang, W.; Wang, S.; Tan, Q. Association of serum uric acid level with muscle strength and cognitive function among Chinese aged 50-74 years. Geriatr. Gerontol. Int. 2013, 13, 672–677. [Google Scholar] [CrossRef] [PubMed]
  34. Dong, X.W.; Tian, H.Y.; He, J.; Wang, C.; Qiu, R.; Chen, Y.M. Elevated Serum Uric Acid Is Associated with Greater Bone Mineral Density and Skeletal Muscle Mass in Middle-Aged and Older Adults. PLoS ONE 2016, 11, e154692. [Google Scholar] [CrossRef] [Green Version]
  35. Macchi, C.; Molino-Lova, R.; Polcaro, P.; Guarducci, L.; Lauretani, F.; Cecchi, F.; Bandinelli, S.; Guralnik, J.M.; Ferrucci, L. Higher circulating levels of uric acid are prospectively associated with better muscle function in older persons. Mech. Ageing Dev. 2008, 129, 522–527. [Google Scholar] [CrossRef]
  36. Lee, J.; Hong, Y.S.; Park, S.H.; Kang, K.Y. High serum uric acid level is associated with greater handgrip strength in the aged population. Arthritis Res. Ther. 2019, 21, 73. [Google Scholar] [CrossRef] [Green Version]
  37. Molino-Lova, R.; Sofi, F.; Pasquini, G.; Vannetti, F.; Del, R.S.; Vassalle, C.; Clerici, M.; Sorbi, S.; Macchi, C. Higher uric acid serum levels are associated with better muscle function in the oldest old: Results from the Mugello Study. Eur. J. Intern. Med. 2017, 41, 39–43. [Google Scholar] [CrossRef]
  38. Park, C.; Obi, Y.; Streja, E.; Rhee, C.M.; Catabay, C.J.; Vaziri, N.D.; Kovesdy, C.P.; Kalantar-Zadeh, K. Serum uric acid, protein intake and mortality in hemodialysis patients. Nephrol Dial. Transpl. 2017, 32, 1750–1757. [Google Scholar] [CrossRef] [Green Version]
  39. Alexandrov, N.V.; Eelderink, C.; Singh-Povel, C.M.; Navis, G.J.; Bakker, S.; Corpeleijn, E. Dietary Protein Sources and Muscle Mass over the Life Course: The Lifelines Cohort Study. Nutrients 2018, 10, 1471. [Google Scholar] [CrossRef] [Green Version]
  40. Aparicio, V.A.; Marin-Jimenez, N.; Coll-Risco, I.; de la Flor-Alemany, M.; Baena-Garcia, L.; Acosta-Manzano, P.; Aranda, P. Doctor, ask your perimenopausal patient about her physical fitness; association of self-reported physical fitness with cardiometabolic and mental health in perimenopausal women: The FLAMENCO project. Menopause 2019, 26, 1146–1153. [Google Scholar] [CrossRef]
  41. Won, H.Y.; Park, J.B.; Park, E.Y.; Riew, K.D. Effect of hyperglycemia on apoptosis of notochordal cells and intervertebral disc degeneration in diabetic rats. J. Neurosurg Spine 2009, 11, 741–748. [Google Scholar] [CrossRef] [PubMed]
  42. Wang, J.; Markova, D.; Anderson, D.G.; Zheng, Z.; Shapiro, I.M.; Risbud, M.V. TNF-alpha and IL-1beta promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc. J. Biol. Chem. 2011, 286, 39738–39749. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Dagistan, Y.; Cukur, S.; Dagistan, E.; Gezici, A.R. Importance of IL-6, MMP-1, IGF-1, and BAX Levels in Lumbar Herniated Disks and Posterior Longitudinal Ligament in Patients with Sciatic Pain. World Neurosurg. 2015, 84, 1739–1746. [Google Scholar] [CrossRef] [PubMed]
  44. Gregorio-Arenas, E.; Ruiz-Cabello, P.; Camiletti-Moiron, D.; Moratalla-Cecilia, N.; Aranda, P.; Lopez-Jurado, M.; Llopis, J.; Aparicio, V.A. The associations between physical fitness and cardiometabolic risk and body-size phenotypes in perimenopausal women. Maturitas 2016, 92, 162–167. [Google Scholar] [CrossRef]
  45. Supriya, R.; Yu, A.P.; Lee, P.H.; Lai, C.W.; Cheng, K.K.; Yau, S.Y.; Chan, L.W.; Yung, B.Y.; Siu, P.M. Yoga training modulates adipokines in adults with high-normal blood pressure and metabolic syndrome. Scand. J. Med. Sci Sports 2018, 28, 1130–1138. [Google Scholar] [CrossRef] [Green Version]
  46. Konieczna, J.; Abete, I.; Galmes, A.M.; Babio, N.; Colom, A.; Zulet, M.A.; Estruch, R.; Vidal, J.; Toledo, E.; Diaz-Lopez, A.; et al. Body adiposity indicators and cardiometabolic risk: Cross-sectional analysis in participants from the PREDIMED-Plus trial. Clin. Nutr. 2019, 38, 1883–1891. [Google Scholar] [CrossRef]
  47. Keswell, D.; Tootla, M.; Goedecke, J.H. Associations between body fat distribution, insulin resistance and dyslipidaemia in black and white South African women. Cardiovasc. J. Afr. 2016, 27, 177–183. [Google Scholar] [CrossRef] [Green Version]
  48. Ormazabal, V.; Nair, S.; Elfeky, O.; Aguayo, C.; Salomon, C.; Zuniga, F.A. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc. Diabetol. 2018, 17, 122. [Google Scholar] [CrossRef]
  49. Lee, W.J.; Peng, L.N.; Chiou, S.T.; Chen, L.K. Relative Handgrip Strength Is a Simple Indicator of Cardiometabolic Risk among Middle-Aged and Older People: A Nationwide Population-Based Study in Taiwan. PLoS ONE 2016, 11, e160876. [Google Scholar] [CrossRef] [Green Version]
  50. Lee, M.R.; Jung, S.M.; Kim, H.S.; Kim, Y.B. Association of muscle strength with cardiovascular risk in Korean adults: Findings from the Korea National Health and Nutrition Examination Survey (KNHANES) VI to VII (2014-2016). Medicine 2018, 97, e13240. [Google Scholar] [CrossRef]
  51. Giudice, J.; Taylor, J.M. Muscle as a paracrine and endocrine organ. Curr. Opin. Pharmacol. 2017, 34, 49–55. [Google Scholar] [CrossRef] [PubMed]
  52. Bostrom, P.; Wu, J.; Jedrychowski, M.P.; Korde, A.; Ye, L.; Lo, J.C.; Rasbach, K.A.; Bostrom, E.A.; Choi, J.H.; Long, J.Z.; et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481, 463–468. [Google Scholar] [CrossRef] [PubMed]
  53. Seldin, M.M.; Peterson, J.M.; Byerly, M.S.; Wei, Z.; Wong, G.W. Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J. Biol. Chem. 2012, 287, 11968–11980. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Table
Table 1. Baseline characteristics of the participants.
Table 1. Baseline characteristics of the participants.
MenWomenAll
Sample size (n, %)231 (67.9%)109 (32.1%)340 (100%)
Age (n, %)
≤30 years20 (8.7%)11 (10.1%)31 (9.1%)
31–40 years80 (34.6%)41 (37.6%)121 (35.6%)
41–50 years60 (26.0%)31 (28.4%)91 (26.8%)
51–60 years71 (30.7%)26 (23.9%)97 (28.5%)
BMI (n, %)
24–27.9 (overweight)192 (83.1%)92 (84.4%)284 (83.5%)
≥ 28.0 (obese)39 (16.9%)17 (15.6%)56 (16.5%)
HPF indicators
Skeletal muscle mass (kg) a33.07 ± 2.8624.40 ± 2.4930.29 ± 4.86
Skeletal muscle mass index (kg/m2) a 11.00 ± 0.629.17 ± 0.6810.43 ± 1.06
Body fat mass (kg) b20.00 (5.80)24.10 (5.00)21.20 (6.40)
Body fat percentage (%)b 25.00 (5.06)35.55 (4.34)27.48 (9.64)
Grip strength (kg) b 36.50 (9.40)25.60 (5.20)33.60 (11.10)
Sit-and-reach (cm) b 4.10 (11.50)9.15 (11.80)5.90 (11.00)
Vital capacity (mL) a 3957.94 ± 844.102708.75 ± 624.923564.65 ± 979.17
Vital capacity index (mL/kg) a 50.66 ± 10.5939.71 ± 9.5447.40 ± 11.44
CVD risk factors
UA (umol/L) b 384.00 (72.00)301.50 (65.00)363.00 (97.00)
TG (mmol/L) b 1.35 (0.79)1.10 (0.65)1.27 (0.79)
HDL-C (mmol/L) a 1.32 ± 0.241.54 ± 0.251.38 ± 0.42
LDL-C (mmol/L) b 2.96 (0.74)2.65 (0.91)2.92 (0.86)
TG/HDL-C ratio b 1.01 (0.70)0.70 (0.53)0.91 (0.72)
GLU (mmol/L) a 5.03 ± 0.435.07 ± 0.42 5.05 ± 0.51
Note: a Data are represented by mean ± SD; b Data are represented by median (IQR). Abbreviations: BMI: body mass index; UA: uric acid; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; GLU: blood glucose.
Table
Table 2. Associations between health-related physical fitness (HPF) indicators and cardiovascular disease (CVD) risk factors.
Table 2. Associations between health-related physical fitness (HPF) indicators and cardiovascular disease (CVD) risk factors.
Dependent Variables aIndependent Variables aββ (95%CI)SEpR2
SMI0.159(0.001, 0.318)0.0810.049 *
BFP0.239(0.076, 0.402)0.0830.004 *
UAGS0.139(0.018, 0.259)0.0610.024 *0.363
SRT0.027(−0.068, 0.122)0.0480.579
VCI0.031(−0.086, 0.147)0.0590.608
SMI0.162(−0.030, 0.353)0.0970.098
BFP0.421(0.226, 0.617)0.0990.000 *
TGGS0.031(−0.113, 0.175)0.0730.6730.098
SRT−0.036(−0.149, 0.078)0.0580.538
VCI0.047(−0.092, 0.187)0.0710.507
SMI−0.183(−0.370, 0.003)0.0950.054
BFP0.014(−0.177, 0.205)0.0970.887
HDL-CGS0.244(0.103, 0.385)0.0720.001 *0.128
SRT−0.009(−0.121, 0.103)0.0570.871
VCI0.066(−0.072, 0.203)0.0700.349
SMI0.045(−0.148, 0.238)0.0540.646
BFP0.131(−0.068, 0.330)0.0100.197
LDL-CGS−0.009(−0.155, 0.136)0.0050.9000.063
SRT0.097(−0.019, 0.212)0.0040.102
VCI0.004(−0.138, 0.147)0.0040.954
SMI0.150(−0.043, 0.344)0.0990.128
BFP0.259(0.061, 0.457)0.1010.011 *
TG/HDL-CGS−0.054(−0.201, 0.092)0.0740.4650.070
SRT−0.029(−0.145, 0.087)0.0590.622
VCI−0.008(−0.151, 0.134)0.0720.909
SMI0.181(−0.007, 0.369)0.0960.059
BFP0.128(−0.065, 0.321)0.0980.192
GLUGS0.035(−0.107, 0.177)0.0720.6300.083
SRT−0.130(−0.243, −0.017)0.0570.024 *
VCI−0.052(−0.190, 0.086)0.0700.461
Note: the multiple linear regression model controlled for sex and age; a indicates the variable was z-standardized; * indicates statistical significance (p < 0.05); SE indicates standard error. Abbreviations: UA: uric acid; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; GLU: blood glucose; SMI: skeletal muscle index; BFP: body fat percentage; GS: grip strength; SRT: sit-and-reach test; VCI: vital capacity index.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Chen, J.; Zhou, Y.; Pan, X.; Li, X.; Long, J.; Zhang, H.; Zhang, J. Associations between Health-Related Physical Fitness and Cardiovascular Disease Risk Factors in Overweight and Obese University Staff. Int. J. Environ. Res. Public Health 2020, 17, 9031. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph17239031

AMA Style

Chen J, Zhou Y, Pan X, Li X, Long J, Zhang H, Zhang J. Associations between Health-Related Physical Fitness and Cardiovascular Disease Risk Factors in Overweight and Obese University Staff. International Journal of Environmental Research and Public Health. 2020; 17(23):9031. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph17239031

Chicago/Turabian Style

Chen, Jiangang, Yuan Zhou, Xinliang Pan, Xiaolong Li, Jiamin Long, Hui Zhang, and Jing Zhang. 2020. "Associations between Health-Related Physical Fitness and Cardiovascular Disease Risk Factors in Overweight and Obese University Staff" International Journal of Environmental Research and Public Health 17, no. 23: 9031. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph17239031

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop